Select a Region North America


Vivienne Ho, PhD

Associate Partner


Consulting (Strategy Management & Regulatory), Consulting (Strategy Management and HTA requirements), Launch Readiness, Medical Affairs, Patient Journey, Product Launch, Research & Insights

As an Associate Partner at EVERSANA MANAGEMENT CONSULTING, Vivienne Ho combines over five years of pharmaceutical consulting experience with 10 years of biomedical research and scientific training to provide support from strategy to execution.

Vivienne builds valuable partnerships with commercialization teams and is experienced in areas such as product launch, pipeline asset strategy development, benchmarking, brand strategy and planning, market shaping, field team optimization and engagement strategy, medical affairs excellence and patient services development. Therapeutic areas of expertise include immunology, dermatology, rheumatology, GI, oncology, CNS, rare disease, women’s health and diagnostics.

Prior to joining EVERSANA, Vivienne held a series of progressive roles at Herspiegel Consulting, most recently as a Senior Manager leading product launches, post-launch strategy development, medical affairs strategy and execution, and primary and secondary research-based benchmarking studies.
Vivienne received her PhD in biomedical sciences from the University of Connecticut Health Center, focusing her thesis work on cell biology and developmental angiogenesis. She also earned a BA from Colby College, majoring in biology and classics.

Articles by Vivienne Ho, PhD

Breaking through Barriers: Critical Success Factors for Launching Products with Breakthrough Therapy Designation

The FDA’s Breakthrough Therapy Designation (BTD) expedites patient access to innovative new treatments. While speeding up these processes can get new drugs to patients in need faster than they normally would through standard tracks, limited clinical evidence at launch and a compressed launch timeline can present stumbling blocks and uncertainties for commercialization teams tackling launch strategy, planning and execution. A differentiated product will contribute to broader adoption in the marketplace, but that is not the sole factor determining its success. Launch teams must understand that they can control and shape the product’s trajectory. Download the white paper to learn more about the implications of launching BTD products and some critical […]

Interested in scheduling a meeting or speaking event?